0001567619-19-006548.txt : 20190311 0001567619-19-006548.hdr.sgml : 20190311 20190311153331 ACCESSION NUMBER: 0001567619-19-006548 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190311 DATE AS OF CHANGE: 20190311 EFFECTIVENESS DATE: 20190311 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Erasca, Inc. CENTRAL INDEX KEY: 0001761918 IRS NUMBER: 831217027 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-330625 FILM NUMBER: 19672156 BUSINESS ADDRESS: STREET 1: 10835 ROAD TO THE CURE, SUITE 140 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 465-6511 MAIL ADDRESS: STREET 1: 10835 ROAD TO THE CURE, SUITE 140 CITY: SAN DIEGO STATE: CA ZIP: 92121 D/A 1 primary_doc.xml X0708 D/A LIVE 0001761918 Erasca, Inc. 10835 Road to The Cure, Ste. 140 San Diego CA CALIFORNIA 92121 (858) 465-6511 DELAWARE None None Corporation true 2018 Jonathan E. Lim, M.D. 10835 Road to The Cure, Ste. 140 San Diego CA CALIFORNIA 92121 Executive Officer Director President and Executive Chairman Gary Yeung, CFA 10835 Road to The Cure, Ste. 140 San Diego CA CALIFORNIA 92121 Executive Officer Chief Business Officer James A. Bristol, Ph.D. 10835 Road to The Cure, Ste. 140 San Diego CA CALIFORNIA 92121 Director Alexander W. Casdin 10835 Road to The Cure, Ste. 140 San Diego CA CALIFORNIA 92121 Director Pratik S. Multani, M.D. 10835 Road to The Cure, Ste. 140 San Diego CA CALIFORNIA 92121 Director Valerie Harding-Start 10835 Road to The Cure, Ste. 140 San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b true 0001567619-19-001152 2018-10-30 false true false 0 70000000 58278287 11721713 false 41 0 0 0 false Erasca, Inc. /s/ Jonathan E. Lim, M.D. Jonathan E. Lim, M.D. President 2019-03-11